Back
Intra-Cellular Therapies Stock Price Chart
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
26
ITCI
Intra-Cellular Therapies
Last Price:
77.06
Seasonality Move:
-4.41%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.11 | Buy |
| 20-day SMA: | 74.12 | Buy |
| 50-day SMA: | 75.78 | Buy |
| 200-day SMA: | 70.5 | Buy |
| 8-day EMA: | 75.2 | Buy |
| 20-day EMA: | 74.76 | Buy |
| 50-day EMA: | 74.42 | Buy |
| 200-day EMA: | 69.87 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 61.02 | Buy |
| Chaikin Money Flow: | 455173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.18 - 75.7) | Buy |
| Bollinger Bands (100): | (68.22 - 76.74) | Buy |
Intra-Cellular Therapies Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 76.97 while ITCI 8-day simple moving average is 75.11, which is a Buy signal.
- The stock price of ITCI is 76.97 while Intra-Cellular Therapies 20-day SMA is 74.12, which makes it a Buy.
- Intra-Cellular Therapies 50-day simple moving average is 75.78 while ITCI share price is 76.97, making it a Buy technically.
- ITCI stock price is 76.97 and Intra-Cellular Therapies 200-day simple moving average is 70.50, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Sell
26
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Sell
The current Intra-Cellular Therapies [ITCI] share price is $76.97. The Score for ITCI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
8.13B
Price in USD:
76.97
Share Volume:
544.3K
Intra-Cellular Therapies 52-Week Range
52-Week High:
84.89
52-Week Low:
45.50
Sell
26
Intra-Cellular Therapies (ITCI)
is a Sell
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 76.97 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 76.97 while ITCI 8-day exponential moving average is 75.20, which is a Buy signal.
- The stock price of ITCI is 76.97 while Intra-Cellular Therapies 20-day EMA is 74.76, which makes it a Buy.
- Intra-Cellular Therapies 50-day exponential moving average is 74.42 while ITCI share price is 76.97, making it a Buy technically.
- ITCI stock price is 76.97 and Intra-Cellular Therapies 200-day simple moving average is 69.87, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 61.02, which suggest Intra-Cellular Therapies is overbought
- The Bollinger Bands (25) for Intra-Cellular Therapies is (73.18 - 75.7), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is (68.22 - 76.74), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.